全文获取类型
收费全文 | 3431篇 |
免费 | 209篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 85篇 |
儿科学 | 125篇 |
妇产科学 | 57篇 |
基础医学 | 368篇 |
口腔科学 | 183篇 |
临床医学 | 448篇 |
内科学 | 717篇 |
皮肤病学 | 18篇 |
神经病学 | 355篇 |
特种医学 | 281篇 |
外科学 | 308篇 |
综合类 | 72篇 |
预防医学 | 262篇 |
眼科学 | 17篇 |
药学 | 205篇 |
1篇 | |
中国医学 | 8篇 |
肿瘤学 | 135篇 |
出版年
2021年 | 31篇 |
2020年 | 23篇 |
2019年 | 47篇 |
2018年 | 45篇 |
2017年 | 24篇 |
2016年 | 44篇 |
2015年 | 40篇 |
2014年 | 55篇 |
2013年 | 128篇 |
2012年 | 141篇 |
2011年 | 173篇 |
2010年 | 96篇 |
2009年 | 75篇 |
2008年 | 137篇 |
2007年 | 147篇 |
2006年 | 155篇 |
2005年 | 173篇 |
2004年 | 112篇 |
2003年 | 97篇 |
2002年 | 101篇 |
2001年 | 90篇 |
2000年 | 108篇 |
1999年 | 69篇 |
1998年 | 62篇 |
1997年 | 49篇 |
1996年 | 62篇 |
1995年 | 64篇 |
1994年 | 55篇 |
1993年 | 56篇 |
1992年 | 67篇 |
1991年 | 65篇 |
1990年 | 73篇 |
1989年 | 95篇 |
1988年 | 92篇 |
1987年 | 96篇 |
1986年 | 93篇 |
1985年 | 65篇 |
1984年 | 63篇 |
1983年 | 46篇 |
1982年 | 35篇 |
1981年 | 29篇 |
1980年 | 36篇 |
1979年 | 28篇 |
1978年 | 33篇 |
1977年 | 28篇 |
1976年 | 28篇 |
1975年 | 26篇 |
1974年 | 21篇 |
1973年 | 23篇 |
1972年 | 16篇 |
排序方式: 共有3645条查询结果,搜索用时 31 毫秒
61.
62.
Lina A Ricciardelli David Mellor Marita P McCabe Alexander J Mussap David J Hallford Matthew Tyler 《BMC public health》2012,12(1):28
Background
Overall the physical health of Indigenous men is among the worst in Australia. Research has indicated that modifiable lifestyle factors, such as poor nutrition and physical inactivity, appear to contribute strongly to these poor health conditions. To effectively develop and implement strategies to improve the health of Australia's Indigenous peoples, a greater understanding is needed of how Indigenous men perceive health, and how they view and care for their bodies. Further, a more systematic understanding of how sociocultural factors affect their health attitudes and behaviours is needed. This article presents the study protocol of a community-based investigation into the factors surrounding the health and body image of Indigenous Australian men. 相似文献63.
64.
W. O. Tobin J. A. Kinsella G. F. Kavanagh J. S. O’Donnell R. A. McGrath D. R. Collins T. Coughlan D. O’Neill B. Egan S. Tierney T. M. Feeley R. P. Murphy Dominick J. H. McCabe 《Journal of neurology》2013,260(2):590-596
The impact of changing antiplatelet therapy on thrombin generation potential in patients with ischaemic cerebrovascular disease (CVD) is unclear. We assessed patients within 4 weeks of TIA or ischaemic stroke (baseline), and then 14 days (14d) and >90 days (90d) after altering antiplatelet therapy. Thrombin generation was assessed in platelet poor plasma. Ninety-one patients were recruited. Twenty-four were initially assessed on no antiplatelet therapy, and then after 14d (N = 23) and 90d (N = 8) on aspirin monotherapy; 52 were assessed on aspirin monotherapy, and after 14 and 90 days on aspirin and dipyridamole combination therapy; 21 patients were assessed on aspirin and after 14 days (N = 21) and 90 days (N = 19) on clopidogrel. Peak thrombin generation and endogenous thrombin potential were reduced at 14 and 90 days (p ≤ 0.04) in the overall cohort. We assessed the impact of individual antiplatelet regimens on thrombin generation parameters to investigate the cause of this effect. Lag time and time-to-peak thrombin generation were unchanged at 14 days, but reduced 90 days after commencing aspirin (p ≤ 0.009). Lag time, peak thrombin generation and endogenous thrombin potential were reduced at both 14 and 90 days after adding dipyridamole to aspirin (p ≤ 0.01). Lag time was reduced 14 days after changing from aspirin to clopidogrel (p = 0.045), but this effect was not maintained at 90 days (p = 0.2). This pilot study did not show any consistent effects of commencing aspirin, or of changing from aspirin to clopidogrel on thrombin generation potential during follow-up. The addition of dipyridamole to aspirin led to a persistent reduction in peak and total thrombin generation ex vivo, and illustrates the diverse, potentially beneficial, newly recognised ‘anti-coagulant’ effects of dipyridamole in ischaemic CVD. 相似文献
65.
66.
Giugliano RP Roe MT Harrington RA Gibson CM Zeymer U Van de Werf F Baran KW Hobbach HP Woodlief LH Hannan KL Greenberg S Miller J Kitt MM Strony J McCabe CH Braunwald E Califf RM;INTEGRITI Investigators 《Journal of the American College of Cardiology》2003,41(8):1251-1260
OBJECTIVES: The goal of this study was to evaluate combinations of eptifibatide with reduced-dose tenecteplase (TNK) in ST-elevation myocardial infarction (STEMI). BACKGROUND: Glycoprotein IIb/IIIa inhibitors enhance thrombolysis. The role of combination therapy in clinical practice remains to be established. METHODS: Patients (n = 438) with STEMI <6 h were enrolled. In dose-finding, 189 patients were randomized to different combinations of double-bolus eptifibatide and reduced-dose TNK. In dose-confirmation, 249 patients were randomized 1:1 to eptifibatide 180 microg/kg bolus, 2 microg/kg/min infusion, and 180 microg/kg bolus 10 min later (180/2/180) plus half-dose TNK (0.27 mg/kg) or standard-dose (0.53 mg/kg) TNK monotherapy. All patients received aspirin and unfractionated heparin (60 U/kg bolus; infusion 7 U/kg/h [combination], 12 U/kg/h [monotherapy]). The primary end point was Thrombolysis In Myocardial Infarction (TIMI) grade 3 epicardial flow at 60 min. RESULTS: In dose-finding, TIMI grade 3 flow rates were similar across groups (64% to 68%). Arterial patency was highest for eptifibatide 180/2/180 plus half-dose TNK (96%, p = 0.02 vs. eptifibatide 180/2/90 plus half-dose TNK). In dose-confirmation, this combination, compared with TNK monotherapy, tended to achieve more TIMI 3 flow (59% vs. 49%, p = 0.15), arterial patency (85% vs. 77%, p = 0.17), and ST-segment resolution (median 71% vs. 61%, p = 0.08) but was associated with more major hemorrhage (7.6% vs. 2.5%, p = 0.14) and transfusions (13.4% vs. 4.2%, p = 0.02). Intracranial hemorrhage occurred in 1.0%, 0.6%, and 1.7% of patients treated with any combination, eptifibatide 180/2/180 and half-dose TNK, and TNK monotherapy, respectively. CONCLUSIONS: Double-bolus eptifibatide (180/2/180) plus half-dose TNK tended to improve angiographic flow and ST-segment resolution compared with TNK monotherapy but was associated with more transfusions and non-cerebral bleeding. Further study is needed before this combination can be recommended for general use. 相似文献
67.
68.
Ortiz-Alvarez O; Cabral D; Prendiville JS; Stringer D; Petty RE; Malleson PN 《Rheumatology (Oxford, England)》1997,36(2):280-284
Two children are reported in whom intestinal pseudo-obstruction was the
initial manifestation of systemic sclerosis. Gastrointestinal symptoms and
skin changes resolved or improved in both children following treatment with
prednisone and penicillamine (case 1) or methotrexate (case 2), although
radiological changes of the gastrointestinal tract persisted at 3 and 2 yr
of follow-up, respectively.
相似文献
69.
Members of the synaptobrevin/vesicle-associated membrane protein (VAMP) family in Drosophila are functionally interchangeable in vivo for neurotransmitter release and cell viability
下载免费PDF全文
![点击此处可从《Proceedings of the National Academy of Sciences of the United States of America》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Bhattacharya S Stewart BA Niemeyer BA Burgess RW McCabe BD Lin P Boulianne G O'Kane CJ Schwarz TL 《Proceedings of the National Academy of Sciences of the United States of America》2002,99(21):13867-13872
Synaptobrevins or VAMPs are vesicle-associated membrane proteins, often called v-SNARES, that are important for vesicle transport and fusion at the plasma membrane. Drosophila has two characterized members of this gene family: synaptobrevin (syb) and neuronal synaptobrevin (n-syb). Mutant phenotypes and gene-expression patterns indicate that n-Syb is exclusively neuronal and required only for synaptic vesicle secretion, whereas Syb is ubiquitous and, as shown here, essential for cell viability. When the eye precursor cells were made homozygous for syb(-), the eye failed to develop. In contrast, n-syb(-) eye clones developed appropriately but failed to activate downstream neurons. To determine whether the two proteins are structurally specialized to accomplish these distinct in vivo functions, we have driven the expression of each gene in the absence of the other to look for phenotypic rescue. We find that expression of n-syb during eye development can rescue the cell lethality of the syb mutations, as can rat VAMP2 and cellubrevin. Expression of syb can restore synaptic transmission to n-syb mutants as assayed both by electroretinogram and recordings of excitatory junctional currents at the neuromuscular junction. Therefore, we find that Syb, which usually is not involved in synaptic function, can mediate Ca(2+)-triggered synaptic activity and that no particular specialization of the v-SNARE is required to differentiate synaptic exocytosis from other forms. 相似文献
70.
Jacqueline AM Smith DL Patil OT Daniels Y-S Ding J-D Gallezot S Henry KHS Kim S Kshirsagar WJ Martin GP Obedencio E Stangeland PR Tsuruda W Williams RE Carson ST Patil 《The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)》2015,18(2)